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Aim: To use a platform to analyze a subgroup specialized in evaluation of patients candidates
to  IOERT.
Background: Medting is a project that was initiated to support daily clinical activity, knowl-
edge  management and medical education by sharing information with other physicians.
The  project began at the “Hospital General Universitario Gregorio Maran˜ón”, which has a
dedicated oncology physician’s multi-specialist committee. There are many scientiﬁc social
networks all over the world. Medting is the only platform that specializes in healthcare and
has  been developed for hospital purposes.
Materials and methods: Medting brings all together the relevant clinical information from
electronic medical records and picture archiving about the patient to study. Subplatform
Medting-IORT was created on February 2, 2012 at the Hospital General Universitario Gregorio
Maran˜on. It has 23 members, have been registered 18 cases with 238 multimedia images.
Results: Medting started with 28 physicians and ﬁve departments. After 6 months, proof of
concept period, there are 225 physicians, more than 120 medical students and 39 depart-
ments in 3 hospitals using the scientiﬁc social network. Furthermore, the project is being
extended on three more hospitals in Madrid.
Conclusion: Medting gives the opportunity to oncology physicians to access all relevant clin-
ical  information with the ability to discuss case notes and view images at any time. The
impact of the Medting platform in a subgroup working team to evaluate IOERT patients can-didates is included in the analysis. The use of a constantly updated repository based on real
cases and the documentation of the internal activity of the tumor committee beyond the
medical record, has become an extraordinary tool for teaching, training and learning.
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1.  Background
Medting is a project that was initiated to support daily clinical
activity, knowledge management and medical education by
sharing information with other physicians. The project began
in March 2010 and is active in speciﬁc programs (including
radiation oncology).1
Medting can be deﬁned as a Scientiﬁc Social Network for
medical professionals. The main purpose for which it was
created is to support the activities of the Tumor Commit-
tee.
The project began at the “Hospital General Universitario
Gregorio Maran˜ón”, which has a dedicated oncology physi-
cian’s multi-specialist committee. Therefore, with a Scientiﬁc
Social Network clinicians can work in a more efﬁcient and
interdisciplinary manner, improving knowledge surrounding
clinical problems and helping to improve medical care. The
hospital determined that using a scientiﬁc social network
facilitates collection of data, allows greater interaction and
more efﬁcient sharing of anticipated information with other
physicians and oncology centers. All these advantages have
led to the expansion of this network to ﬁve additional hospi-
tals.
There are many  scientiﬁc social networks all over the
world. In the USA, the following may be mentioned: sermo,
physician connect, student doctor network, relaxdoc, clini-
cal village, iMed exchange, medtrust, MyPacs. . .In Europe we
have: doc2doc, onMedica, Coliquio, Docchech, Esanum, Doox,
Docatus. . .
Some of these networks function as follows:
- Sermo is an online community for physicians founded in
2006 by Daniel Palestrant. Users can register after verifying
their status as licensed practicing physicians and receive a
pseudonym of their choice. This pseudonym and the doc-
tor’s specialty are the only pieces of information that other
doctors will be able to see automatically. Doctors post obser-
vations and comments, create and respond to surveys, and
browse medical articles within the site. Members say they
don not mind their conversations are accessible to others,
particularly since their identities are concealed.2–4
- Coliquio is a trusted and secure platform accessible exclu-
sively to physicians, offering real time dialog, exchange and
interaction in clinical and non clinical forums, knowledge
centers, treatment guidelines, certiﬁed education resources
and latest medical news.5
- MedTrust is a scientiﬁc social network that was created
in order to provide excellent management and healthcare
stafﬁng service in the commercial sector. Actually, it is con-
sidered a veteran owned business providing medical stafﬁng
solutions and service to their customers at numerous loca-
tions around the United States.6
- Doc2doc is an online social and business-related networking
website such as Facebook or Lindekin. The aim of this social
network is to promote public health by providing powerful
7instruments for communication and education.
David L. Graham said that: “Social media, when applied
to medicine, can have three uses: it can accelerate theiotherapy 1 9 ( 2 0 1 4 ) 253–258
development of communities (both personal and profes-
sional), it can serve as a marketing tool, and it can function
as a method of knowledge dissemination”.8
2.  Aim
Medting is the only platform that specializes in healthcare
and was developed for hospital purposes. A subgroup spe-
cialized in evaluation of patients candidates to IOERT has
used the platform to explore the interest in recording and
discussing this speciﬁc medical activity. The speciﬁc charac-
teristics related to IOERT activity are described.
3.  Materials  and  methods
Hospital General Universitario Gregorio Maran˜ón has a dedi-
cated oncology physician’s multi-specialist committee, where
they discuss each individual case, have speciﬁc treatment tar-
gets and review of patients who are newly  diagnosed. Each
case is presented and agreed by consensus to create the best
and optimal treatment including clinical, surgical, therapeu-
tic and/or palliative care. Physicians gather information from
different sources and share it in the committee. Normally,
such information is presented as a power point presentation.
Medting brings all together the relevant clinical information
from electronic medical records and picture archiving about
the patient to study. In this way, the physician can share
virtually the case and not only on the day of tumor commit-
tee. Within this context, Medting would permit physicians
to gain opinions in advance of the weekly meeting, share
the information with other oncology centers and also enable
ongoing dialog with both immediate colleagues and special-
ists in other departments. Therefore, this Scientiﬁc Social
Network enables to focus on clinical case presentation and
image sharing, supports clinical decision making and is a place
where researchers, clinicians, medical students and residents
can share and learn.
As a web site where any medical professional can share
clinical cases, images or videos, incorporating their own ﬁles
and browsing the information that already exists (the system
protects data conﬁdentiality). The potential for quality clini-
cal practice is promoted. A speciﬁc functionality is integrated
from other systems, such as Pubmed, to provide the access to
a free digital archive, or Snomed, allowing to narrow a search
in cases which the user is interested is, is also available.
Subplatform Medting-IORT was created on February 2, 2012
at the Hospital General Universitario Gregorio Maran˜on. It has
23 members, have been registered 18 cases with 238 multime-
dia images (Fig. 1).
This subplatform completes each case study in the follow-
ing three distinct steps:
- First is a narrative report of the case, presenting the patient’slowed, including whether the patient received adjuvant
treatment; type of surgery; IORT. . .This component regis-
tration includes all information needed to fully evaluate the
case complexity (Fig. 2).
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Fig. 1 – Front page of MEDTING website.
-
- Second, there is a visor with imaging recording of the most
relevant studies: CT scans, MRI  and, particularly in the
IORT group, multimedia images are added of a treatment
planning system (Radiance). Thus, illustrated information
is provided about the typical case analyses, bevel, energy,
dose, surgical approach, exact location of the tumor and its
relationship with adjacent organs.  . .(Fig. 3).
 Finally, the third element available in the case-oriented-
platform is formed by the set of comments, ideas, opinions
and contributions of other professionals. This will create a
tool that allows a multidisciplinary communication to study
each case, so as to follow the evolution of each patient
recorded.
Fig. 2 – First element of the pA maximized, complete, comprehensive and continuing
evaluation in each individual case is facilitated building a mul-
tidisciplinary approach.
4.  Results
Medting is a project started with 28 physicians and ﬁve
departments. After six months, there are 225 physicians,
more  than 120 medical students and 39 departments in three
hospitals using the scientiﬁc social network. Furthermore,
the project is being extended to three more  hospitals in
Madrid.
latform: clinical report.
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le ofFig. 3 – Second element of the platform “viewer”: examp
This web side involves Medting software based on Intel
architecture. The collaboration is based on providing a Web-
based platform, which is the purpose of Medting, and
developing capabilities that include data encryption, graph-
ics features and powerful processing, all ensured by the Intel
architecture. These features are essential for a social network
and “cloud architecture”.
The goal of this undertaking was to support professional
collaboration, to share experiences and to learn at both
national and international levels. In order to be launched, this
project should be easy to use, providing security and protec-
tion of private data, and be incorporated seamlessly into the
existing technology infrastructure.
Thereby, a combination of hardware, software and process
is provided to sufﬁciently support the underlying platform.
Finally, there was only a technological challenge: it was
important for this social network to be available always and
everywhere. This objective was achieved. Mobile workﬂow,
where information is available as and where it is needed, pos-
itively impacts the quality of clinical decisions.
Keeping up a regular contact with the patient data enables
to make decisions based on full knowledge, to reduce potential
errors and to minimize the chances for the patient’s conditions
to change during the time between diagnosis and treatment
delivery.
The results obtained from the use of the subplatform IORT-
Medting are as follows:
There have been 18 cases registered. Six rectal tumors,
4 sarcomas, 3 breast tumors, 2 cervix tumors, 1 pancreatic
tumor, 1 gastric tumor and 1 endometrial tumor.
4.1.  Rectal  cancer
Of the 6 rectal tumors, 4 are primary tumors and 2 recurrences.
Only one of the primary cases received neoadjuvant therapy.
Surgical treatment: 2 were treated with distal colectomy, one
with abdomino perineal amputation, one with low anterior
resection and 2 with ultralow anterior resection. The 6 tumors
received IORT. an treatment planning imaging for an IOERT procedure.
4.2.  Soft  tissue  sarcomas
Of the 4 sarcomas, 2 are primary tumors and 2 recurrences.
Surgical treatment: two were treated with adhesiolysis, one
with hemipelvectomy and another one with bloc resection and
splenectomy. The 4 tumors received IORT.
4.3.  Breast  cancer
Of the 3 breast tumors, all three were primary. Surgical treat-
ment: 2 were treated with lumpectomy one of which included
lymphadenectomy, and the other was treated with segmen-
tectomy. The 3 tumors received IORT.
4.4.  Uterine  cervix  cancer
Of the 2 cervix cancer, both were recurrence tumors, one
intercavo-aortic and one para-aortic. Surgical treatment: the
ﬁrst was irresectable, and the other one was treated with lym-
phadenectomy. The 2 tumors received IORT.
4.5.  Pancreatic  cancer
The only reported case of pancreatic cancer was a primary
tumor; it was treated surgically with hemicolectomy and pan-
creaticoduodenectomy. It received IORT.
4.6.  Gastric  cancer
The only reported case of gastric cancer was a recurrence
tumor; it was treated surgically with pancreaticoduodenec-
tomy. It received IORT.
4.7.  Endometrial  cancerThe only reported case of endometrial cancer was a recurrence
tumor; it was treated surgically with cytoreduction with pelvic
exenteration. It received IORT.
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.  Discussion
hen Medting was created, there were three essential chal-
enges to meet:
 The appropriateness of the social networking aspects of
the project for clinical use had not previously been demon-
strated. Expectations and outcomes were deﬁned in the
context of a proof of concept, which ran over ﬁve months.
 A “community manager” was needed to be able to resolve
questions and problems that can appear as the physi-
cians use the social network and to overcome the initial
incredulity of managers and clinicians in an oncology con-
text.
 The project was not initially seen as a priority. The aim was
to check if the application of a scientiﬁc social network was
possible in a clinical context, so the approval of the health
managers was required.
The proof of concept project was launched at the Hospital
eneral Universitario Gregorio Maran˜on. Until then, physi-
ians had to collect the information for the Tumor Board
resentations from different sources including the electronic
ospital chart and put them into a format that would be easy
or their colleagues to understand. Generally, each case was
resented on paper, or at best as a Microsoft Power Point pre-
entation. Therefore, the ﬁrst impression that emerged from
he use of this type of Scientiﬁc Social Network was charac-
erized by a high level of user acceptance and satisfaction.9
The results are explained because Medting gives the oppor-
unity to oncology physicians to access to all relevant clinical
nformation with the ability to discuss case notes and view
mages at any time. Also, all comments and all the knowledge
rovided by any colleague are stoned as part of the discussion
rocess and the cases can be shared with physicians anytime
nd anywhere.
The value of this social network within the context of
ncology cannot be overstated. Cancer is a multidisciplinary
isease in both diagnostic and therapeutic terms. The man-
gement decision in these patients is based on biological
haracteristic of neoplastic tissue and the different surgical
ossibilities (radical, conservative.  . .).  The use of pharmaceu-
ical compounds and radiation therapy technology should also
e included in this discussion. Therefore, there is a clear
eed for an interdisciplinary approach to cancer treatments.
his innovative project demonstrates the need of using social
etworks for clinical collaboration and knowledge sharing.
o, taking into account that the therapeutic cancer approach
s based on an interdisciplinary communication, improving
his aspect will obviously optimize the oncology treatments
nd diagnosis. Furthermore, the use of a constantly updated
epository based on real cases and the documentation of the
nternal activity of the tumor committee beyond the medical
ecord, has become an extraordinary tool of teaching, training
nd learning.All oncological institutions, international scientiﬁc onco-
ogical societies, expert cancer hospitals, advanced health
nstitutions and medical specialists practicing oncology stress
he need and usefulness of a multidisciplinary management oftherapy 1 9 ( 2 0 1 4 ) 253–258 257
cancer patients. This requires good communication between
professionals in order to take charge of the patient, as well
as a method to share all patient information in the decision
making process. MEDTING enables to share all patient data
that could be useful in medical research, as well as images
ranging from imaging tests such as X-rays, CT, MRI, to images
of histological and pathological tumor and also allows to add
laboratory data and everything that is necessary to develop
a diagnostic and therapeutic process based on a consensus of
opinions of different experts in different branches of medicine
that can provide knowledge to optimize clinical practice. Users
in addition to presenting their view on the cases can also
have access whenever and wherever they want. All this makes
this web site one virtual tumor board that improves patient
multidisciplinary approach, which results in better diagnos-
tic and therapeutic decisions by consensus and is likely to
improve oncology clinical practice. All this is not conﬁned to
any individual hospital as the scientiﬁc social network can
be expanded to other hospitals in a national or international
level. At the moment, the international sharing of cancer
knowledge is based on access to databases that hold informa-
tion on clinical trial selections or evidence-based diagnostic
and treatment recommendations.10
Standardization of clinical practice in super-specialized
treatment modalities such as IOERT is a mandatory require-
ment for quality care. Our experience with the IORT
subplatform is consistent with the added value of medical
evaluation exhaustively found for the Tumor Board project and
the improved multi-specialist contribution to case-by-case
evaluation. Subgroups and sub-platforms have an optimized
potential for externalizing opinions, care consultation with
expert physicians and groups and relevant teaching contri-
bution of typical cases analyses, self-training and electronic
tutorials.
Additionaly we are considering extending the project to dif-
ferent hospitals in Spain for other radiotherapy applications,
treatment planning evaluation,11 comparison of dosimetric
characteristics12 and for patients with different cancers types,
treated not only through IOERT.
6.  Conclusion
The scientiﬁc social network improves clinical outcomes while
ensuring better communication among clinicians. Medting
provides a new model of international oncology collaboration.
It can quite easily be globalized while retaining its individual
nature so that patients can receive multimodal cancer treat-
ments in the form of personalized care.13
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